CH637018A5 - Mittel zur verbesserung der durchblutung und wundheilung. - Google Patents
Mittel zur verbesserung der durchblutung und wundheilung. Download PDFInfo
- Publication number
- CH637018A5 CH637018A5 CH1626777A CH1626777A CH637018A5 CH 637018 A5 CH637018 A5 CH 637018A5 CH 1626777 A CH1626777 A CH 1626777A CH 1626777 A CH1626777 A CH 1626777A CH 637018 A5 CH637018 A5 CH 637018A5
- Authority
- CH
- Switzerland
- Prior art keywords
- blood
- tissue
- extract
- kinins
- kinin
- Prior art date
Links
- 230000035876 healing Effects 0.000 title claims 6
- 206010052428 Wound Diseases 0.000 title claims 5
- 208000027418 Wounds and injury Diseases 0.000 title claims 5
- 230000004087 circulation Effects 0.000 title claims 4
- 239000003918 blood extract Substances 0.000 claims description 15
- 101800004538 Bradykinin Proteins 0.000 claims description 13
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims description 13
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims description 13
- 238000001802 infusion Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 4
- 239000008274 jelly Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 238000001361 intraarterial administration Methods 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 108010093008 Kinins Proteins 0.000 claims 19
- 102000002397 Kinins Human genes 0.000 claims 19
- 210000001519 tissue Anatomy 0.000 claims 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 12
- 239000008103 glucose Substances 0.000 claims 12
- 230000017531 blood circulation Effects 0.000 claims 10
- 239000000126 substance Substances 0.000 claims 10
- 239000000284 extract Substances 0.000 claims 8
- 102400000967 Bradykinin Human genes 0.000 claims 7
- 239000008280 blood Substances 0.000 claims 6
- 210000004369 blood Anatomy 0.000 claims 6
- 244000309466 calf Species 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 5
- 238000006243 chemical reaction Methods 0.000 claims 4
- 239000003978 infusion fluid Substances 0.000 claims 4
- 239000002674 ointment Substances 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 238000012360 testing method Methods 0.000 claims 4
- 230000029663 wound healing Effects 0.000 claims 4
- 102000001399 Kallikrein Human genes 0.000 claims 3
- 108060005987 Kallikrein Proteins 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 150000001413 amino acids Chemical group 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000007924 injection Substances 0.000 claims 3
- 238000002347 injection Methods 0.000 claims 3
- 230000002093 peripheral effect Effects 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 108010003195 Kallidin Proteins 0.000 claims 2
- FYSKZKQBTVLYEQ-FSLKYBNLSA-N Kallidin Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CCC1 FYSKZKQBTVLYEQ-FSLKYBNLSA-N 0.000 claims 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims 2
- 206010053648 Vascular occlusion Diseases 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 230000000172 allergic effect Effects 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 229940088710 antibiotic agent Drugs 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000015556 catabolic process Effects 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000002474 experimental method Methods 0.000 claims 2
- 230000007794 irritation Effects 0.000 claims 2
- 230000004060 metabolic process Effects 0.000 claims 2
- 230000003389 potentiating effect Effects 0.000 claims 2
- 239000012088 reference solution Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 208000021331 vascular occlusion disease Diseases 0.000 claims 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims 1
- 206010002199 Anaphylactic shock Diseases 0.000 claims 1
- LQJAALCCPOTJGB-YUMQZZPRSA-N Arg-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O LQJAALCCPOTJGB-YUMQZZPRSA-N 0.000 claims 1
- 206010056340 Diabetic ulcer Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 108010077861 Kininogens Proteins 0.000 claims 1
- 102000010631 Kininogens Human genes 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108010038807 Oligopeptides Proteins 0.000 claims 1
- 102000015636 Oligopeptides Human genes 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- 238000000692 Student's t-test Methods 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 206010058990 Venous occlusion Diseases 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 208000003455 anaphylaxis Diseases 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000036770 blood supply Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000023852 carbohydrate metabolic process Effects 0.000 claims 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 claims 1
- 230000003727 cerebral blood flow Effects 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 claims 1
- 210000004913 chyme Anatomy 0.000 claims 1
- 230000001904 diabetogenic effect Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000001105 femoral artery Anatomy 0.000 claims 1
- 230000035558 fertility Effects 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 230000004153 glucose metabolism Effects 0.000 claims 1
- 230000004190 glucose uptake Effects 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 230000009027 insemination Effects 0.000 claims 1
- 230000001689 kallikreinlike Effects 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000011707 mineral Chemical class 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 238000007427 paired t-test Methods 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229940107700 pyruvic acid Drugs 0.000 claims 1
- 238000011160 research Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 210000002460 smooth muscle Anatomy 0.000 claims 1
- 229940005581 sodium lactate Drugs 0.000 claims 1
- 239000001540 sodium lactate Substances 0.000 claims 1
- 235000011088 sodium lactate Nutrition 0.000 claims 1
- 238000010972 statistical evaluation Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- 238000011870 unpaired t-test Methods 0.000 claims 1
- 230000000304 vasodilatating effect Effects 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- 239000003357 wound healing promoting agent Substances 0.000 claims 1
- 102100035792 Kininogen-1 Human genes 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/043—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2700043A DE2700043C2 (de) | 1977-01-03 | 1977-01-03 | Mittel zur Verbesserung der Durchblutung und Wundheilung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH637018A5 true CH637018A5 (de) | 1983-07-15 |
Family
ID=5998057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1626777A CH637018A5 (de) | 1977-01-03 | 1978-01-01 | Mittel zur verbesserung der durchblutung und wundheilung. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4177261A (en, 2012) |
| JP (1) | JPS53104713A (en, 2012) |
| AT (1) | AT356262B (en, 2012) |
| CH (1) | CH637018A5 (en, 2012) |
| DE (1) | DE2700043C2 (en, 2012) |
| FR (1) | FR2375868A1 (en, 2012) |
| GB (1) | GB1562871A (en, 2012) |
| NL (1) | NL188681C (en, 2012) |
| SE (1) | SE443510B (en, 2012) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT389640B (de) * | 1985-10-16 | 1990-01-10 | Chemie Holding Ag | Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH639247A5 (de) * | 1979-01-23 | 1983-11-15 | Thera Ges Fuer Patente | Aminosaeuren und mineralsalze enthaltende infusionsloesung. |
| US5468737A (en) * | 1982-05-07 | 1995-11-21 | Carrington Laboratories, Inc. | Wound healing accelerated by systemic administration of polysaccharide from aloe |
| CA1243957A (en) * | 1983-06-03 | 1988-11-01 | Laszlo Bogdany | Compositions for cosmetic, health- and body- preserving use |
| HU190723B (en) * | 1983-06-03 | 1986-10-28 | Caola Kozmetikai | Cosmetical composition containing protein-trace element adducts and process for producing them |
| US5165938A (en) * | 1984-11-29 | 1992-11-24 | Regents Of The University Of Minnesota | Wound healing agents derived from platelets |
| US4937230A (en) * | 1985-01-24 | 1990-06-26 | Procyte Corporation | Method of healing wounds in horses |
| US5348943A (en) * | 1985-02-08 | 1994-09-20 | Procyte Corporation | Cosmetic and skin treatment compositions |
| US5214032A (en) * | 1985-02-08 | 1993-05-25 | Procyte Corporation | GHL-CU pharmaceutical compositions and compounds |
| US4810693A (en) * | 1985-02-08 | 1989-03-07 | Procyte Corporation | Method for inducing biological coverings in wounds |
| US5177061A (en) * | 1985-02-08 | 1993-01-05 | Procyte Corporation | Method for stimulating hair growth using GHL-Cu complexes |
| US5550183A (en) * | 1985-02-08 | 1996-08-27 | Procyte Corporation | Metal-peptide compositions and methods for stimulating hair growth |
| US5120831A (en) * | 1985-02-08 | 1992-06-09 | Procyte Corporation | Metal-peptide compositions |
| WO1988008695A1 (en) * | 1987-05-11 | 1988-11-17 | Procyte Corporation | Methods for stimulating hair growth |
| US5145838A (en) * | 1989-08-30 | 1992-09-08 | Procyte Corporation | Methods and compositions for healing ulcers |
| US5023237A (en) * | 1989-08-30 | 1991-06-11 | Procyte Corporation | Methods and compositions for healing ulcers |
| US5059588A (en) * | 1989-10-13 | 1991-10-22 | Procyte Corporation, Incorporated | Methods and compositions for healing bone using gly his lys: copper |
| US5118665A (en) * | 1990-02-09 | 1992-06-02 | Procyte Corporation | Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof |
| US5164367A (en) * | 1990-03-26 | 1992-11-17 | Procyte Corporation | Method of using copper(ii) containing compounds to accelerate wound healing |
| JPH05163158A (ja) * | 1991-12-13 | 1993-06-29 | Sanwa Kagaku Kenkyusho Co Ltd | 人尿性キニノゲナーゼを有効成分とする皮膚潰瘍の予防及び治療剤 |
| KR0163563B1 (ko) * | 1994-03-23 | 1998-12-01 | 김종인 | 피부질환 치료용 의약조성물 |
| US5538945A (en) * | 1994-06-17 | 1996-07-23 | Procyte Corporation | Stimulation of hair growth by peptide copper complexes |
| EP0726413B1 (de) * | 1995-02-13 | 1998-11-25 | Cci Ag | Eigenmediumbetätigtes Ventil |
| US5733884A (en) * | 1995-11-07 | 1998-03-31 | Nestec Ltd. | Enteral formulation designed for optimized wound healing |
| US20020076782A1 (en) * | 1996-07-05 | 2002-06-20 | John P.N. Rosazza | Purified nitric oxide synthase |
| US20080199513A1 (en) * | 1997-06-24 | 2008-08-21 | Cascade Medical Enterprises, Llc | Systems and methods for preparing autologous fibrin glue |
| US7745106B2 (en) * | 1997-06-24 | 2010-06-29 | Cascade Medical Enterprises, Llc | Methods and devices for separating liquid components |
| US6979307B2 (en) * | 1997-06-24 | 2005-12-27 | Cascade Medical Enterprises Llc | Systems and methods for preparing autologous fibrin glue |
| AU2763099A (en) | 1998-06-22 | 2000-01-10 | Charles E. Worden | Enriched platelet wound healant |
| RU2209074C2 (ru) * | 2001-08-29 | 2003-07-27 | Общество с ограниченной ответственностью "Олимп" | Состав для лечения ожогов |
| RU2222317C2 (ru) * | 2001-10-01 | 2004-01-27 | Российский научный центр "Восстановительная травматология и ортопедия" им. акад. Г.А.Илизарова | Средство для стимуляции эпителизации раны |
| US20080190857A1 (en) * | 2005-03-22 | 2008-08-14 | Cascade Medical Entrprises, Llc | System and Methods of Producing Membranes |
| RU2303987C1 (ru) * | 2006-06-27 | 2007-08-10 | Ооо "Нпф Ренам" | Способ получения препарата для лечения дефектов кожи |
| US20090197892A1 (en) * | 2007-08-21 | 2009-08-06 | Nawaz Ahmad | Anhydrous compositions useful for attaining enhanced sexual wellness |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2912359A (en) * | 1955-05-04 | 1959-11-10 | Developments Inc | Wound healing agent obtained from blood and method of preparation |
| JPS5220524B1 (en, 2012) * | 1968-11-02 | 1977-06-04 | ||
| DE2357507C3 (de) * | 1973-11-17 | 1980-07-31 | Bayer Ag, 5090 Leverkusen | Mittel zur Fertilitätssteigemng |
-
1977
- 1977-01-03 DE DE2700043A patent/DE2700043C2/de not_active Expired
- 1977-12-29 FR FR7739646A patent/FR2375868A1/fr active Granted
- 1977-12-29 JP JP16093477A patent/JPS53104713A/ja active Granted
- 1977-12-30 US US05/865,912 patent/US4177261A/en not_active Expired - Lifetime
-
1978
- 1978-01-01 CH CH1626777A patent/CH637018A5/de not_active IP Right Cessation
- 1978-01-02 NL NLAANVRAGE7800014,A patent/NL188681C/xx not_active IP Right Cessation
- 1978-01-02 SE SE7800021A patent/SE443510B/sv not_active IP Right Cessation
- 1978-01-03 GB GB79/78A patent/GB1562871A/en not_active Expired
- 1978-01-03 AT AT4078A patent/AT356262B/de not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT389640B (de) * | 1985-10-16 | 1990-01-10 | Chemie Holding Ag | Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2375868A1 (fr) | 1978-07-28 |
| NL7800014A (nl) | 1978-07-05 |
| NL188681C (nl) | 1992-09-01 |
| JPS53104713A (en) | 1978-09-12 |
| SE443510B (sv) | 1986-03-03 |
| SE7800021L (sv) | 1978-07-04 |
| GB1562871A (en) | 1980-03-19 |
| AT356262B (de) | 1980-04-25 |
| JPS6324976B2 (en, 2012) | 1988-05-23 |
| DE2700043A1 (de) | 1978-07-06 |
| FR2375868B1 (en, 2012) | 1982-06-11 |
| US4177261A (en) | 1979-12-04 |
| ATA4078A (de) | 1979-09-15 |
| DE2700043C2 (de) | 1983-12-08 |
| NL188681B (nl) | 1992-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH637018A5 (de) | Mittel zur verbesserung der durchblutung und wundheilung. | |
| EP0619737B1 (de) | Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung | |
| DE69737144T2 (de) | Antimikrobielle behandlung von herpes simplex viren und anderer infektioser erkrankungen | |
| DE69709682T2 (de) | Gruene salbe | |
| CA1335262C (en) | Pharmaceutical composition for treatment of mastitis in amimals and humans | |
| DE3827533A1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus | |
| DE69027220T2 (de) | Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen | |
| DE69033112T2 (de) | Zink enthaltende Sprays | |
| DE60115433T2 (de) | Verfahren zur behandlung von chronischen geschwüren | |
| DE3323389A1 (de) | Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden | |
| JPH04501106A (ja) | 動物およびヒトにおける乳腺炎の治療用医薬 | |
| DE69705110T2 (de) | Topische pharmazeutische zusammensetzungen, welche heparin enthalten | |
| DE69231036T2 (de) | Verfahren zur behandlung von patienten mit chronischer lebererkrankung | |
| DE2658984C2 (de) | Injizierbare Insulinpräparate | |
| EP0001124A1 (de) | Neue Arzneimittelmischungen zur Verbesserung der Glucoseverwertung in den Zellen und Senkung des Blutzuckerspiegels | |
| EP0710480B1 (de) | Arzneimittelszusammensetzung aus S-Milchsäure und dessen Verwendung | |
| DE19732323C2 (de) | Medikamentenkombination zur erhöhten Wirkstoffkonzentration in Geweben | |
| DE2444652A1 (de) | Mittel zur bekaempfung lokaler schmerzen | |
| DE102009024542A1 (de) | Zusammensetzungen auf Basis von Chitosan-Oligosacchariden | |
| SU1139444A1 (ru) | Способ введени нейротропных и гормональных препаратов | |
| DE1947896A1 (de) | Pharmazeutische Zubereitungen und ihre Herstellung | |
| DE2657381C2 (de) | Glucosehaltige Infusionslösung | |
| RU2356557C2 (ru) | Гомеопатическое средство для лечения и профилактики эндометрита животных | |
| DE3439805C2 (de) | Verwendung von Argininaspartat zur Behandlung der Hypotrophie | |
| DE2759793C2 (de) | Mittel zur Verbesserung der Durchblutung und Wundheilung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUE | Assignment |
Owner name: HORMON-CHEMIE MUENCHEN GMBH |
|
| PL | Patent ceased |